ClinicalTrials.gg
Status unknownNCT03132051Updated Apr 27, 2017

Sonographic Evaluation of Patients With Carpal Tunnel Syndrome Following Steroid Injection

An interventional study of steroid injection in Carpal Tunnel Syndrome, sponsored by Taipei Veterans General Hospital, Taiwan. Status unknown at 1 site in Taiwan. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2017-04-27.

Sponsored by Taipei Veterans General Hospital, Taiwan · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2017), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 3 years 10 months after the study started (first participant enrolled Apr 2013, registered Feb 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The objective of this study was to assess sonographic changes of the median nerve after steroid injection for carpal tunnel syndrome.

Read the detailed description

Patients with CTS were recruited. The Boston Questionnaire (BQ) was administered and ultrasonographic and electrophysiological examinations were performed before and at two, six, and 12 weeks after steroid injection. Cross sectional area (CSA) was measured at 2 levels: at the tunnel inlet and in the mid-carpal tunnel. Flattening ratio (FR) was measured only in the mid-carpal tunnel. Correlation analyses between baseline ultrasonography, BQ, and electrophysiological measures were performed.

02

Conditions studied

  • Carpal Tunnel Syndrome

Keywords

  • carpal tunnel syndrome
03

In context

Carpal Tunnel Syndrome

605 studies on the registry are indexed under Carpal Tunnel Syndrome; 138 are open to participants now.

This study's planned enrollment of 54 is close to the median of 60 across 457 interventional studies indexed under Carpal Tunnel Syndrome.

Browse Carpal Tunnel Syndrome studies →

Lead sponsor

Taipei Veterans General Hospital, Taiwan is the lead sponsor of 338 studies on the registry; 74 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. clinical diagnosis of CTS
  2. The diagnosis of CTS was confirmed by electrophysiological tests.

Exclusion criteria

Exclusion Criteria:

  1. neurologic disorders that could mimic CTS such as cervical radiculopathy, polyneuropathy, proximal median nerve entrapment, or thoracic outlet syndrome
  2. history of distal radius fracture
  3. pregnancy or lactation
  4. regular use of systemic NSAIDs or corticosteroids
  5. known allergy to corticosteroids and local anesthetics.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
54 participants (estimated)

Study arms

  • Experimental
    steroid injection

    ultrasound-guided steroid injection using 1ml of 10 mg (10mg/ml) triamcinolone acetonide

    Drug: steroid injection

Interventions

  • ultrasound-guided steroid injection using 1ml of 10 mg (10mg/ml) triamcinolone acetonide

    Also known as: triamcinolone acetonide

06

What researchers measure

Primary outcomes

  1. Cross sectional area

    The CSA of the median nerve was measured at 2 levels: at the carpal tunnel inlet (CSA-I; immediately prior to the proximal margin of the flexor retinaculum) and in the mid-carpal tunnel (CSA-M; at the level of the pisiform bone and scaphoid tubercle)

    Time frame: 12 weeks

Secondary outcomes

  1. flattening ratio

    The flattening ratio was measured only at the mid-tunnel (FR-M). FR was calculated by dividing the horizontal diameter of the nerve by the vertical diameter.

    Time frame: 2, 6, 12 weeks

  2. Boston Carpal Tunnel Questionnaire (BQ)

    The BQ was interviewed-administered to assess the severity of symptoms and functional status.

    Time frame: 2, 6, 12 weeks

  3. Median nerve distal motor latency

    the CMAPs were obtained via surface electrodes placed on the abductor pollicis brevis muscle. The active recording electrode was placed on the muscle belly, and the reference electrode was placed on the tendon insertion. The median nerve was stimulated 8 cm proximal to the active recording electrode. Distal motor latencies were measured from the onset of stimulus artifact to the onset of the CMAP

    Time frame: 2, 6, 12 weeks

  4. sensory nerve conduction velocity

    SNAPs were obtained using an antidromic method and recorded by surface electrodes placed at the proximal and distal interphalangeal joints of the index finger for the median nerve and the same joints of the little finger for the ulnar nerve. The median nerves were stimulated at the wrist at a distance of 14 cm from the wrist to the active electrode. Distal sensory latencies were measured from the onset of the stimulus artifact to the onset of the SNAP. SNCV was calculated dividing the distance of 14 cm by the distal sensory latency.

    Time frame: 2, 6, 12 weeks

  5. compound muscle action potential amplitude (CMAP)

    the CMAPs were obtained via surface electrodes placed on the abductor pollicis brevis muscle. The active recording electrode was placed on the muscle belly, and the reference electrode was placed on the tendon insertion. The median nerve was stimulated 8 cm proximal to the active recording electrode. The amplitude of CMAP were measured from baseline to negative peak.

    Time frame: 2, 6, 12 weeks

  6. sensory nerve action potential amplitudes.

    SNAPs were obtained using an antidromic method and recorded by surface electrodes placed at the proximal and distal interphalangeal joints of the index finger for the median nerve and the same joints of the little finger for the ulnar nerve. The median nerves were stimulated at the wrist at a distance of 14 cm from the wrist to the active electrode. The amplitude of SNAP were measured from baseline to negative peak.

    Time frame: 2, 6, 12 weeks

07

Study locations

1 of 1 sites recruiting
  • Teipei Veterans General Hospital
    Taipei, Taiwan
    • Jia chi Wang, MD · Contact · 886-2-28757361
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 27, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03132051
Responsible party
Sponsor
First posted
Apr 27, 2017
Start date
Apr 2013
Primary completion
Feb 2018 (estimated)
Completion
Feb 2018 (estimated)
Last update
Apr 27, 2017

Study contacts

Jia chi Wang, MD
Contact
jcwang0726@gmail.com
886-2-28757361
Jia chi Wang
principal investigator · Taipei Veteran General hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Steroids

Start the discussion